A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin
Status:
COMPLETED
Trial end date:
2025-02-14
Target enrollment:
Participant gender:
Summary
The purpose of this Real-World Evidence study is to generate real world data from participants with cough associated with the common cold, evaluating the effects in two arms with commercially available cough syrups on health-related quality of life (QoL). Arm 1 includes one cough syrup (which can be used day or night) and Arm 2 includes the daytime cough syrup and a nighttime cough syrup.